Cerebral venous sinus thrombosis following ChAdOx1 nCoV-19 AstraZeneca COVID-19 vaccine

Cerebral venous sinus thrombosis following ChAdOx1 nCoV-19 AstraZeneca COVID-19 vaccine

A woman in her mid-twenties was admitted with headache, ultimately leading to a diagnosis of cerebral venous sinus thrombosis 10 days after receiving a first dose of the AstraZeneca ChAdOx1 nCoV-19 vaccine (Vaxzevria). We report this case from clinical investigations to outcomes and discuss the issu...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:JRSM cardiovascular disease 2023-01, Vol.12, p.204800402311694
Hauptverfasser: Sharma, Shyam S, Gulli, Giosue, Sharma, Pankaj
Format: Artikel
Sprache:eng
Schlagworte:
Case Report
Case reports
COVID-19 vaccines
Side effects
Stroke
Thrombosis
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page 204800402311694
container_title JRSM cardiovascular disease
container_volume 12
creator Sharma, Shyam S
Gulli, Giosue
Sharma, Pankaj
description A woman in her mid-twenties was admitted with headache, ultimately leading to a diagnosis of cerebral venous sinus thrombosis 10 days after receiving a first dose of the AstraZeneca ChAdOx1 nCoV-19 vaccine (Vaxzevria). We report this case from clinical investigations to outcomes and discuss the issues raised by it regarding the ChAdOx1 nCoV-19 vaccine.
doi_str_mv 10.1177/20480040231169464
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10107960</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sage_id>10.1177_20480040231169464</sage_id><sourcerecordid>2920172899</sourcerecordid><originalsourceid>FETCH-LOGICAL-c2564-51a9b274654c39981da129b26258665949ed4a53ca930fe9ab6abea465f90d483</originalsourceid><addsrcrecordid>eNp1UU1rwzAMNWODla0_YLfAzuksx3Hi0yjZV6HQy9bBLsZxnDYltTu76bZ_P4eWfTCmgySe3nsSCKELwCOALLsimOYYU0wSAMYpo0do0GNxDx7_6E_R0PsVDsEpYMoG6LnQTpdOttFOG9v5yDcm5O3S2XVpfeOj2ratfWvMIiqW42r2DpEp7DwGHo391skXbbSSUTGbT256cCeVaow-Rye1bL0eHuoZerq7fSwe4unsflKMp7EiKaNxCpKXJKMspSrhPIdKAgkII2nOWMop1xWVaaIkT3CtuSyZLLUM_JrjiubJGbre-266cq0rpU24qRUb16yl-xBWNuL3xDRLsbA7ARhwxhkODpcHB2dfO-23YmU7Z8LRgnCCISM554EFe5Zy1nun668VgEX_BPHnCUEz2mu8XOhv1_8Fn4NChOk</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2920172899</pqid></control><display><type>article</type><title>Cerebral venous sinus thrombosis following ChAdOx1 nCoV-19 AstraZeneca COVID-19 vaccine</title><source>Sage Journals GOLD Open Access 2024</source><source>PubMed Central</source><source>EZB Electronic Journals Library</source><creator>Sharma, Shyam S ; Gulli, Giosue ; Sharma, Pankaj</creator><creatorcontrib>Sharma, Shyam S ; Gulli, Giosue ; Sharma, Pankaj</creatorcontrib><description>A woman in her mid-twenties was admitted with headache, ultimately leading to a diagnosis of cerebral venous sinus thrombosis 10 days after receiving a first dose of the AstraZeneca ChAdOx1 nCoV-19 vaccine (Vaxzevria). We report this case from clinical investigations to outcomes and discuss the issues raised by it regarding the ChAdOx1 nCoV-19 vaccine.</description><identifier>ISSN: 2048-0040</identifier><identifier>EISSN: 2048-0040</identifier><identifier>DOI: 10.1177/20480040231169464</identifier><language>eng</language><publisher>London, England: SAGE Publications</publisher><subject>Case Report ; Case reports ; COVID-19 vaccines ; Side effects ; Stroke ; Thrombosis</subject><ispartof>JRSM cardiovascular disease, 2023-01, Vol.12, p.204800402311694</ispartof><rights>The Author(s) 2023</rights><rights>The Author(s) 2023. This work is licensed under the Creative Commons Attribution License https://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>The Author(s) 2023 2023 SAGE Publications</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c2564-51a9b274654c39981da129b26258665949ed4a53ca930fe9ab6abea465f90d483</citedby><cites>FETCH-LOGICAL-c2564-51a9b274654c39981da129b26258665949ed4a53ca930fe9ab6abea465f90d483</cites><orcidid>0000-0003-4729-4803</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC10107960/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC10107960/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,21966,27853,27924,27925,44945,45333,53791,53793</link.rule.ids></links><search><creatorcontrib>Sharma, Shyam S</creatorcontrib><creatorcontrib>Gulli, Giosue</creatorcontrib><creatorcontrib>Sharma, Pankaj</creatorcontrib><title>Cerebral venous sinus thrombosis following ChAdOx1 nCoV-19 AstraZeneca COVID-19 vaccine</title><title>JRSM cardiovascular disease</title><description>A woman in her mid-twenties was admitted with headache, ultimately leading to a diagnosis of cerebral venous sinus thrombosis 10 days after receiving a first dose of the AstraZeneca ChAdOx1 nCoV-19 vaccine (Vaxzevria). We report this case from clinical investigations to outcomes and discuss the issues raised by it regarding the ChAdOx1 nCoV-19 vaccine.</description><subject>Case Report</subject><subject>Case reports</subject><subject>COVID-19 vaccines</subject><subject>Side effects</subject><subject>Stroke</subject><subject>Thrombosis</subject><issn>2048-0040</issn><issn>2048-0040</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><sourceid>AFRWT</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><recordid>eNp1UU1rwzAMNWODla0_YLfAzuksx3Hi0yjZV6HQy9bBLsZxnDYltTu76bZ_P4eWfTCmgySe3nsSCKELwCOALLsimOYYU0wSAMYpo0do0GNxDx7_6E_R0PsVDsEpYMoG6LnQTpdOttFOG9v5yDcm5O3S2XVpfeOj2ratfWvMIiqW42r2DpEp7DwGHo391skXbbSSUTGbT256cCeVaow-Rye1bL0eHuoZerq7fSwe4unsflKMp7EiKaNxCpKXJKMspSrhPIdKAgkII2nOWMop1xWVaaIkT3CtuSyZLLUM_JrjiubJGbre-266cq0rpU24qRUb16yl-xBWNuL3xDRLsbA7ARhwxhkODpcHB2dfO-23YmU7Z8LRgnCCISM554EFe5Zy1nun668VgEX_BPHnCUEz2mu8XOhv1_8Fn4NChOk</recordid><startdate>20230101</startdate><enddate>20230101</enddate><creator>Sharma, Shyam S</creator><creator>Gulli, Giosue</creator><creator>Sharma, Pankaj</creator><general>SAGE Publications</general><general>Sage Publications Ltd</general><scope>AFRWT</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0003-4729-4803</orcidid></search><sort><creationdate>20230101</creationdate><title>Cerebral venous sinus thrombosis following ChAdOx1 nCoV-19 AstraZeneca COVID-19 vaccine</title><author>Sharma, Shyam S ; Gulli, Giosue ; Sharma, Pankaj</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c2564-51a9b274654c39981da129b26258665949ed4a53ca930fe9ab6abea465f90d483</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>Case Report</topic><topic>Case reports</topic><topic>COVID-19 vaccines</topic><topic>Side effects</topic><topic>Stroke</topic><topic>Thrombosis</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Sharma, Shyam S</creatorcontrib><creatorcontrib>Gulli, Giosue</creatorcontrib><creatorcontrib>Sharma, Pankaj</creatorcontrib><collection>Sage Journals GOLD Open Access 2024</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>JRSM cardiovascular disease</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Sharma, Shyam S</au><au>Gulli, Giosue</au><au>Sharma, Pankaj</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Cerebral venous sinus thrombosis following ChAdOx1 nCoV-19 AstraZeneca COVID-19 vaccine</atitle><jtitle>JRSM cardiovascular disease</jtitle><date>2023-01-01</date><risdate>2023</risdate><volume>12</volume><spage>204800402311694</spage><pages>204800402311694-</pages><issn>2048-0040</issn><eissn>2048-0040</eissn><abstract>A woman in her mid-twenties was admitted with headache, ultimately leading to a diagnosis of cerebral venous sinus thrombosis 10 days after receiving a first dose of the AstraZeneca ChAdOx1 nCoV-19 vaccine (Vaxzevria). We report this case from clinical investigations to outcomes and discuss the issues raised by it regarding the ChAdOx1 nCoV-19 vaccine.</abstract><cop>London, England</cop><pub>SAGE Publications</pub><doi>10.1177/20480040231169464</doi><orcidid>https://orcid.org/0000-0003-4729-4803</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2048-0040
ispartof JRSM cardiovascular disease, 2023-01, Vol.12, p.204800402311694
issn 2048-0040
2048-0040
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10107960
source Sage Journals GOLD Open Access 2024; PubMed Central; EZB Electronic Journals Library
subjects Case Report
Case reports
COVID-19 vaccines
Side effects
Stroke
Thrombosis
title Cerebral venous sinus thrombosis following ChAdOx1 nCoV-19 AstraZeneca COVID-19 vaccine
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-20T17%3A53%3A37IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Cerebral%20venous%20sinus%20thrombosis%20following%20ChAdOx1%20nCoV-19%20AstraZeneca%20COVID-19%20vaccine&rft.jtitle=JRSM%20cardiovascular%20disease&rft.au=Sharma,%20Shyam%20S&rft.date=2023-01-01&rft.volume=12&rft.spage=204800402311694&rft.pages=204800402311694-&rft.issn=2048-0040&rft.eissn=2048-0040&rft_id=info:doi/10.1177/20480040231169464&rft_dat=%3Cproquest_pubme%3E2920172899%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2920172899&rft_id=info:pmid/&rft_sage_id=10.1177_20480040231169464&rfr_iscdi=true